Premium
Safe prescribing of direct oral anticoagulants for non‐valvular AF
Author(s) -
Cheong VLin,
Ali Osman
Publication year - 2021
Publication title -
prescriber
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.106
H-Index - 3
eISSN - 1931-2253
pISSN - 0959-6682
DOI - 10.1002/psb.1911
Subject(s) - medicine , warfarin , atrial fibrillation , intensive care medicine , adverse effect , pharmacology , cardiology
The use of direct oral anticoagulants (DOACs) is becoming increasingly common in primary care. While this group of drugs requires less intensive monitoring than warfarin, safe prescribing is still necessary to achieve optimum therapeutic effect and minimise adverse effects. This article discusses the key principles of safe DOAC prescribing for non‐valvular atrial fibrillation (NVAF), and the systems that general practices can put in place to achieve this.